New York A 2142: Enacts the medical psilocybin act

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A02142 Summary:

BILL NOA02142A

&nbsp

SAME ASSAME AS S05303-A

&nbsp

SPONSORPaulin

&nbsp

COSPNSRLupardo, Hevesi, McDonald, Weprin, Burdick, Stirpe, Taylor, Simon, Kelles

&nbsp

MLTSPNSR

&nbsp

Add Art 33 Title 5-B §§3369-aa - 3369-kk, Pub Health L; add Art 174 §§174.00 - 174.20, Pen L

&nbsp

Authorizes the use of psilocybin to treat qualified medical conditions; prohibits criminal diversion of medical psilocybin.

Go to top A02142 Actions:

BILL NOA02142A

&nbsp

01/15/2025referred to health

01/07/2026referred to health

05/08/2026amend (t) and recommit to health

05/08/2026print number 2142a

Go to topA02142 Committee&nbspVotes:

Go to topA02142 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA02142 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 2142--A

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 15, 2025
 ___________

 Introduced by M. of A. PAULIN, LUPARDO, HEVESI, McDONALD, WEPRIN,
 BURDICK -- read once and referred to the Committee on Health -- recom-
 mitted to the Committee on Health in accordance with Assembly Rule 3,
 sec. 2 -- committee discharged, bill amended, ordered reprinted as
 amended and recommitted to said committee

 AN ACT to amend the public health law and the penal law, in relation to
 authorizing the use of psilocybin to treat qualified medical condi-
 tions

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. This act shall be known and may be cited as the "medical
 2 psilocybin act".
 3 § 2. Article 33 of the public health law is amended by adding a new
 4 title 5-B to read as follows:

 5 TITLE V-B
 6 MEDICAL PSILOCYBIN ACT
 7 Section 3369-aa. Definitions.
 8 3369-bb. Medical use of psilocybin program.
 9 3369-cc. Registry identification cards.
 10 3369-dd. Exemption from criminal and civil penalties for
 11 possession and medical use of psilocybin.
 12 3369-ee. Prohibitions, restrictions and limitations on the use
 13 of psilocybin.
 14 3369-ff. Recordkeeping.
 15 3369-gg. Labelling; warnings.
 16 3369-hh. Safety and testing requirements.
 17 3369-ii. Violations.
 18 3369-jj. Reporting.
 19 3369-kk. Protections for the medical use of psilocybin.
 20 § 3369-aa. Definitions. As used in this title:
 21 1. "Designated caregiver" means the individual designated by a quali-
 22 fied patient in a registry application. A qualified patient may desig-
 23 nate up to two caregivers;

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03342-02-6

 A. 2142--A 2

 1 2. "Licensed healthcare provider" means a person who: (a) is licensed
 2 as a physician, a psychologist or a nurse practitioner under title eight
 3 of the education law; and (b) has completed a two to four hour course as
 4 determined by the commissioner in regulations; provided however, a
 5 registration shall not be denied without cause. Such course may count
 6 toward board certification requirements. To be a licensed healthcare
 7 provider under this title, such licensed professional's authorized scope
 8 of practice does not need to, but may include, medical diagnosis or
 9 treatment of a qualifying health condition or the prescription of medi-
 10 cations;
 11 3. "Licensed producer" means a person or business enterprise, includ-
 12 ing a sole proprietorship, partnership, corporation, limited liability
 13 company, or other business enterprise, who or which has a license from
 14 the department pursuant to this title to grow and harvest or prepare
 15 psilocybin from psilocybin-producing mushrooms, including to compound,
 16 convert, process or manufacture psilocybin products directly or indi-
 17 rectly from psilocybin mushrooms, to package or repackage or label or
 18 relabel the products, and to transport and deliver psilocybin and psilo-
 19 cybin products;
 20 4. "Permitted medical use" means the quantity of psilocybin, dosing
 21 parameters, method of administration, setting, and whether supervised
 22 use is required, for an individual qualified patient as determined by a
 23 licensed healthcare provider as part of an individualized treatment
 24 plan;
 25 5. "Psilocybin" means the naturally occurring psychedelic compound